logo-loader

Avacta's Alastair Smith encouraged by significant progress and share price momentum

Published: 05:17 24 Jan 2019 EST

Alastair Smith, chief executive of Avacta Group PLC (LON:AVCT), caught up with Proactive London's Andrew Scott to talk through a business update released from the firm to coincide with its annual general meeting this week.

Among recent highlights were the partnership with LG Chem, which sent the company’s shares soaring in December, and the research collaboration with leading scientists at Tufts University Medical School.

The company also announced a licensing deal last year with New England Biolabs and appointed Jose Saro as the chief medical officer.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

1 hour, 58 minutes ago